Gabriel Plotkin Teva Pharmaceutical Industries LTD Transaction History
Melvin Capital Management LP
- $0
- Q3 2023
A detailed history of Gabriel Plotkin (Melvin Capital Management LP) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Melvin Capital Management LP holds 3,420,000 shares of TEVA stock, worth $68.4 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
3,420,000Holding current value
$68.4 Million% of portfolio
0.24%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding TEVA
# of Institutions
653Shares Held
663MCall Options Held
30.1MPut Options Held
16.4M-
Black Rock Inc. New York, NY43MShares$860 Million0.02% of portfolio
-
Menora Mivtachim Holdings Ltd.38.5MShares$770 Million3.78% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E938.3MShares$767 Million36.86% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$756 Million5.98% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L337.8MShares$756 Million8.62% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $22.2B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...